Q & A: An Update on Hereditary Transthyretin Amyloidosis Q & A: An Update on Hereditary Transthyretin Amyloidosis
Morie Gertz, MD, reviews hereditary amyloidogenic transthyretin (ATTR) amyloidosis diagnosis and treatment.Medscape (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 4, 2024 Category: Cancer & Oncology Tags: Neurology & Neurosurgery Commentary Source Type: news

Digital Health Sector Slowed Down in 2023 Digital Health Sector Slowed Down in 2023
Although the average amount raised in European funding rounds decreased, the number of investors increased by nearly one quarter.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 3, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

MicroRNAs Predict Pancreatic Cancer Risk Years in Advance MicroRNAs Predict Pancreatic Cancer Risk Years in Advance
Expression levels of several microRNAs in plasma samples can help predict the onset of pancreatic cancer up to 5 years prior to clinical diagnosis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 3, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Clinical Summary Source Type: news

What's Driving Higher Breast Cancer Deaths in Black Women? What's Driving Higher Breast Cancer Deaths in Black Women?
Despite improvements in breast cancer screening and treatment, Black women experience higher death rates and more aggressive forms of the disease than White women.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 3, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Potential Cure for Early BRCA-Mutated Breast Cancer? Potential Cure for Early BRCA-Mutated Breast Cancer?
A small trial found " a remarkable 100% of patients were still alive at 36 months " after receiving olaparib plus standard chemotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Feds Seek Input on Private Equity, Consolidation in Medicine Feds Seek Input on Private Equity, Consolidation in Medicine
A federal investigation aims to evaluate private equity ' s involvement in healthcare consolidation and the potential impact on patient care and worker conditions.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2024 Category: Cancer & Oncology Tags: Family Medicine/Primary Care News Source Type: news

The Long, Controversial Search for a'Cancer Microbiome'The Long, Controversial Search for a'Cancer Microbiome '
Conflicting research and divisive logic dominate the quest to answer a critical question: Do cancer tumors have their own microbiomes, and what would that mean for an eventual cure?Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 1, 2024 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

Cervical Cancer Screening: US PCPs Unclear on Best Practices Cervical Cancer Screening: US PCPs Unclear on Best Practices
A new survey found that most US clinicians may not be following the American Cancer Society ' s cervical cancer screening guidelines, which are based on the most up-to-date evidence.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

J & J Advances $6.475 Billion Settlement Of Talc Cancer Lawsuits J & J Advances $6.475 Billion Settlement Of Talc Cancer Lawsuits
Johnson& Johnson is moving forward with a $6.475 billion proposed settlement of tens of thousands of lawsuits alleging that its baby powder and other talc products...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Tool May Help Prioritize High-Risk Patients for Hysteroscopy Tool May Help Prioritize High-Risk Patients for Hysteroscopy
A new nomogram is intended to identify patients at high risk for endometrial cancer and prioritize them in the hysteroscopy waiting list.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Could Aspirin Help Treat Breast Cancer? Could Aspirin Help Treat Breast Cancer?
A new study found that taking aspirin as adjuvant therapy does not improve outcomes for patients with high-risk nonmetastatic breast cancer.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 30, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Stereotactic Radiosurgery to Treat 15-Plus Brain Metastases? Stereotactic Radiosurgery to Treat 15-Plus Brain Metastases?
A large study supports the use of stereotactic radiosurgery in patients with 15 or more brain metastases, finding improved cognitive outcomes and comparable survival to whole brain radiation.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 30, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Rising Late-Stage CRC Rates Support Screening From Age 45 Rising Late-Stage CRC Rates Support Screening From Age 45
The incidence of distant- and regional-stage colorectal cancer (CRC) has been increasing in individuals aged 46-49 years, a cross-sectional study of stage-stratified CRC found.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 30, 2024 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

EMA Approves Factor VIII Deficiency Clotting Drug EMA Approves Factor VIII Deficiency Clotting Drug
European Union marketing authorization recommended for Altuvoct for hemophilia A caused by factor VIII deficiency.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 26, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Europe Recommends Three Cancer Drugs Europe Recommends Three Cancer Drugs
The European Medicines Agency has recommended Fruzaqla, Truqap, and Eribulin Baxter for use in the treatment of specific colorectal and breast cancers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 26, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news